Indivior Pharmaceuticals, Inc. (INDV)
35.06
+0.50
(+1.45%)
USD |
NASDAQ |
Sep 02, 16:00
35.06
0.00 (0.00%)
After-Hours: 19:41
Indivior Pharmaceuticals Net Income (Annual) : 210.00M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 210.00M |
| December 31, 2024 | 7.00M |
| December 31, 2023 | -129.00M |
| December 31, 2022 | -53.00M |
| December 31, 2021 | 205.00M |
| December 31, 2020 | -148.00M |
| December 31, 2019 | 134.00M |
| December 31, 2018 | 275.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 58.00M |
| December 31, 2016 | 35.00M |
| December 31, 2015 | 228.00M |
| December 31, 2014 | 403.00M |
| December 31, 2013 | 489.00M |
| December 31, 2012 | 607.00M |
| December 31, 2011 | 614.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Supernus Pharmaceuticals, Inc. | -38.55M |
| Liquidia Corp. | -68.92M |
| Corcept Therapeutics, Inc. | 98.17M |
| Prestige Consumer Healthcare, Inc. | 190.30M |
| Harrow, Inc. | -5.139M |